Cargando…
Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
The hospital environment significantly contributes to the onset of healthcare-associated infections (HAIs), which represent one of the most frequent complications occurring in healthcare facilities worldwide. Moreover, the increased antimicrobial resistance (AMR) characterizing HAI-associated microb...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370071/ https://www.ncbi.nlm.nih.gov/pubmed/35966671 http://dx.doi.org/10.3389/fmicb.2022.969863 |
_version_ | 1784766676532723712 |
---|---|
author | Cason, Carolina D’Accolti, Maria Soffritti, Irene Mazzacane, Sante Comar, Manola Caselli, Elisabetta |
author_facet | Cason, Carolina D’Accolti, Maria Soffritti, Irene Mazzacane, Sante Comar, Manola Caselli, Elisabetta |
author_sort | Cason, Carolina |
collection | PubMed |
description | The hospital environment significantly contributes to the onset of healthcare-associated infections (HAIs), which represent one of the most frequent complications occurring in healthcare facilities worldwide. Moreover, the increased antimicrobial resistance (AMR) characterizing HAI-associated microbes is one of the human health’s main concerns, requiring the characterization of the contaminating microbial population in the hospital environment. The monitoring of surface microbiota in hospitals is generally addressed by microbial cultural isolation. However, this has some important limitations mainly relating to the inability to define the whole drug-resistance profile of the contaminating microbiota and to the long time period required to obtain the results. Hence, there is an urgent need to implement environmental surveillance systems using more effective methods. Molecular approaches, including next-generation sequencing and PCR assays, may be useful and effective tools to monitor microbial contamination, especially the growing AMR of HAI-associated pathogens. Herein, we summarize the results of our recent studies using culture-based and molecular analyses in 12 hospitals for adults and children over a 5-year period, highlighting the advantages and disadvantages of the techniques used. |
format | Online Article Text |
id | pubmed-9370071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93700712022-08-12 Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance Cason, Carolina D’Accolti, Maria Soffritti, Irene Mazzacane, Sante Comar, Manola Caselli, Elisabetta Front Microbiol Microbiology The hospital environment significantly contributes to the onset of healthcare-associated infections (HAIs), which represent one of the most frequent complications occurring in healthcare facilities worldwide. Moreover, the increased antimicrobial resistance (AMR) characterizing HAI-associated microbes is one of the human health’s main concerns, requiring the characterization of the contaminating microbial population in the hospital environment. The monitoring of surface microbiota in hospitals is generally addressed by microbial cultural isolation. However, this has some important limitations mainly relating to the inability to define the whole drug-resistance profile of the contaminating microbiota and to the long time period required to obtain the results. Hence, there is an urgent need to implement environmental surveillance systems using more effective methods. Molecular approaches, including next-generation sequencing and PCR assays, may be useful and effective tools to monitor microbial contamination, especially the growing AMR of HAI-associated pathogens. Herein, we summarize the results of our recent studies using culture-based and molecular analyses in 12 hospitals for adults and children over a 5-year period, highlighting the advantages and disadvantages of the techniques used. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9370071/ /pubmed/35966671 http://dx.doi.org/10.3389/fmicb.2022.969863 Text en Copyright © 2022 Cason, D’Accolti, Soffritti, Mazzacane, Comar and Caselli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Cason, Carolina D’Accolti, Maria Soffritti, Irene Mazzacane, Sante Comar, Manola Caselli, Elisabetta Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance |
title | Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance |
title_full | Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance |
title_fullStr | Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance |
title_full_unstemmed | Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance |
title_short | Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance |
title_sort | next-generation sequencing and pcr technologies in monitoring the hospital microbiome and its drug resistance |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370071/ https://www.ncbi.nlm.nih.gov/pubmed/35966671 http://dx.doi.org/10.3389/fmicb.2022.969863 |
work_keys_str_mv | AT casoncarolina nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance AT daccoltimaria nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance AT soffrittiirene nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance AT mazzacanesante nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance AT comarmanola nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance AT casellielisabetta nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance |